首页> 外文期刊>Knee surgery, sports traumatology, arthroscopy: official journal of the ESSKA >Chondrogenesis in a hyaluronic acid scaffold: comparison between chondrocytes and MSC from bone marrow and adipose tissue.
【24h】

Chondrogenesis in a hyaluronic acid scaffold: comparison between chondrocytes and MSC from bone marrow and adipose tissue.

机译:透明质酸支架中的软骨形成:来自骨髓和脂肪组织的软骨细胞与MSC之间的比较。

获取原文
获取原文并翻译 | 示例
           

摘要

Treatment of focal lesions of the articular cartilage of the knee using chondrocytes in a hyaluronic acid (HA) scaffold is already being investigated in clinical trials. An alternative may be to use mesenchymal stem cells (MSC). We have compared articular chondrocytes with MSC from human bone marrow (BM) and adipose tissue (AT), all cultured in HA scaffolds, for their ability to express genes and synthesize proteins associated with chondrogenesis. The cells were expanded in monolayer cultures. After seeding into the scaffold, the chondrocytes were maintained in medium, while the two MSC populations were given a chondrogenic differentiation medium. Chondrogenesis was assessed by real-time RT-PCR for chondrocyte-associated genes, by immunohistochemistry and by ELISA for collagens in the supernatant. Redifferentiation of the dedifferentiated chondrocytes in the HA scaffold was shown by a modest increase in type II collagen mRNA (COL2A1) and reduction in COL1A1. BM-MSC expressed 600-fold higher levels of COL2A1 than chondrocytes after 3 weeks in the scaffold. The levels of aggrecan (AGC1) and COL1A1 were similar for chondrocyte and BM-MSC scaffold cultures, while COL10A1 was higher in the BM-MSC. AT-MSC expressed levels of COL2A1 and COL1A1 similar to chondrocytes, but less AGC1 and COL10A1. Surprisingly, little collagen II protein was observed in the scaffold. Instead, collagen II was found in the culture medium. Chondrogenesis in HA scaffolds was more efficient using BM-MSC than AT-MSC or chondrocytes. Some of the secreted collagen II escaped entrapment in the extracellular space and was detected in the culture medium.
机译:在临床试验中已经在研究使用透明质酸(HA)支架中的软骨细胞治疗膝关节软骨的局灶性病变。另一种选择是使用间充质干细胞(MSC)。我们已经将关节软骨细胞与来自人骨髓(BM)和脂肪组织(AT)的MSC(均在HA支架中培养)进行了比较,以研究它们表达基因和合成与软骨形成相关蛋白的能力。细胞在单层培养物中扩增。植入支架后,将软骨细胞保留在培养基中,同时向两个MSC群体提供软骨分化培养基。通过实时RT-PCR评估软骨细胞相关基因,通过免疫组织化学和通过ELISA评估上清液中的胶原的软骨形成。 II型胶原mRNA(COL2A1)的适度增加和COL1A1的减少显示了HA支架中去分化的软骨细胞的再分化。在支架中放置3周后,BM-MSC表达的COL2A1水平比软骨细胞高600倍。对于软骨细胞和BM-MSC支架培养物,聚集蛋白聚糖(AGC1)和COL1A1的水平相似,而在BM-MSC中,COL10A1较高。 AT-MSC表达的COL2A1和COL1A1与软骨细胞相似,但AGC1和COL10A1少。令人惊讶地,在支架中几乎没有观察到胶原蛋白II蛋白。相反,在培养基中发现了胶原蛋白II。使用BM-MSC比使用AT-MSC或软骨细胞在HA支架中进行软骨形成更为有效。一些分泌的胶原蛋白II逃脱了细胞外空间的包裹,并在培养基中被检测到。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号